Novo Nordisk, Inc. is a major pharmaceutical company that develops medicines, including anti-obesity drugs and insulin. Its lobbying filings show it advocates on health and pharmacy issues, pressing Medicare and Medicaid rules and coverage (including the Treat and Reduce Obesity Act) and on drug pricing/affordability and compounding rules. It hires Arnold & Porter Kaye Scholer LLP to represent its interests.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BOBBY MCMILLIN
The latest disclosures for this client.
ARNOLD & PORTER KAYE SCHOLER LLP
Q3ARNOLD & PORTER KAYE SCHOLER LLP
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
ARNOLD & PORTER KAYE SCHOLER LLP
CASEY BROUHARD
ARNOLD & PORTER KAYE SCHOLER LLP
EUGENIA PIERSON
ARNOLD & PORTER KAYE SCHOLER LLP
LUKE ALBERT
ARNOLD & PORTER KAYE SCHOLER LLP
MICKAYLA STOGSDILL
ARNOLD & PORTER KAYE SCHOLER LLP
RON KIND
ARNOLD & PORTER KAYE SCHOLER LLP
SONJA NESBIT
ARNOLD & PORTER KAYE SCHOLER LLP
MARK EPLEY
ARNOLD & PORTER KAYE SCHOLER LLP
ARNOLD & PORTER KAYE SCHOLER LLP
Q1ARNOLD & PORTER KAYE SCHOLER LLP
Q4ARNOLD & PORTER KAYE SCHOLER LLP
Q3ARNOLD & PORTER KAYE SCHOLER LLP
Q2ARNOLD & PORTER KAYE SCHOLER LLP
Q1